Becton Dickinson 過去の業績
この会社の最新の決算報告書はまだ処理中です
過去 基準チェック /16
Becton Dickinsonは、平均年間12%の収益成長を遂げていますが、 Medical Equipment業界の収益は、年間 成長しています。収益は、平均年間12% 3.1%収益成長率で 成長しています。 Becton Dickinsonの自己資本利益率は5.6%であり、純利益率は7.4%です。
主要情報
12.0%
収益成長率
11.0%
EPS成長率
Medical Equipment 業界の成長 | 8.9% |
収益成長率 | 3.1% |
株主資本利益率 | 5.6% |
ネット・マージン | 7.4% |
次回の業績アップデート | 06 Feb 2025 |
最近の業績更新
Recent updates
Becton, Dickinson and Company Q4: Shifting To High-Growth Areas
Nov 12Are Becton, Dickinson and Company (NYSE:BDX) Investors Paying Above The Intrinsic Value?
Oct 22Here's Why Becton Dickinson (NYSE:BDX) Can Manage Its Debt Responsibly
Sep 30Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery
Sep 13Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy
Aug 06Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price
Jul 16An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued
Jun 27Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
May 24Becton, Dickinson and Company: Stagnating All Along
May 16Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22収支内訳
収支内訳
Becton Dickinson の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
30 Jun 24 | 19,828 | 1,459 | 4,847 | 1,169 |
31 Mar 24 | 19,716 | 1,364 | 4,829 | 1,175 |
31 Dec 23 | 19,492 | 1,265 | 4,843 | 1,214 |
30 Sep 23 | 19,372 | 1,470 | 4,817 | 1,237 |
30 Jun 23 | 19,046 | 1,582 | 4,848 | 1,256 |
31 Mar 23 | 18,809 | 1,556 | 4,791 | 1,266 |
31 Dec 22 | 18,738 | 1,486 | 4,751 | 1,255 |
30 Sep 22 | 18,870 | 1,545 | 4,726 | 1,256 |
30 Jun 22 | 18,958 | 1,412 | 4,774 | 1,324 |
31 Mar 22 | 18,924 | 1,430 | 4,845 | 1,339 |
31 Dec 21 | 18,534 | 1,079 | 4,750 | 1,302 |
30 Sep 21 | 19,131 | 1,514 | 4,720 | 1,279 |
30 Jun 21 | 19,066 | 1,486 | 4,632 | 1,210 |
31 Mar 21 | 18,313 | 1,379 | 4,409 | 1,142 |
31 Dec 20 | 18,207 | 1,507 | 4,346 | 1,117 |
30 Sep 20 | 16,074 | 245 | 4,178 | 1,039 |
30 Jun 20 | 16,917 | 786 | 4,216 | 1,067 |
31 Mar 20 | 17,414 | 923 | 4,313 | 1,057 |
31 Dec 19 | 17,355 | 760 | 4,379 | 1,044 |
30 Sep 19 | 17,290 | 1,081 | 4,334 | 1,032 |
30 Jun 19 | 17,108 | 784 | 4,345 | 1,039 |
31 Mar 19 | 17,036 | 926 | 4,353 | 1,063 |
31 Dec 18 | 17,063 | 894 | 4,325 | 1,071 |
30 Sep 18 | 15,983 | 159 | 4,029 | 1,004 |
30 Jun 18 | 14,747 | 621 | 3,689 | 947 |
31 Mar 18 | 13,503 | -99 | 3,325 | 857 |
31 Dec 17 | 12,251 | 294 | 2,991 | 783 |
30 Sep 17 | 12,093 | 1,030 | 2,953 | 770 |
30 Jun 17 | 12,158 | 759 | 2,947 | 807 |
31 Mar 17 | 12,321 | 1,314 | 2,957 | 827 |
31 Dec 16 | 12,419 | 1,309 | 2,966 | 823 |
30 Sep 16 | 12,483 | 976 | 3,005 | 828 |
30 Jun 16 | 12,312 | 1,139 | 2,966 | 771 |
31 Mar 16 | 12,234 | 810 | 2,988 | 743 |
31 Dec 15 | 11,217 | 688 | 2,767 | 690 |
30 Sep 15 | 10,282 | 695 | 2,563 | 632 |
30 Jun 15 | 9,410 | 815 | 2,350 | 570 |
31 Mar 15 | 8,448 | 1,079 | 2,127 | 529 |
31 Dec 14 | 8,468 | 1,150 | 2,141 | 527 |
30 Sep 14 | 8,446 | 1,185 | 2,145 | 524 |
30 Jun 14 | 8,345 | 974 | 2,117 | 522 |
31 Mar 14 | 8,239 | 941 | 2,102 | 506 |
31 Dec 13 | 8,169 | 930 | 2,091 | 502 |
質の高い収益: BDXには$752.0M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が30th June, 2024に影響を及ぼしています。
利益率の向上: BDXの現在の純利益率 (7.4%)は、昨年(8.3%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: BDXの収益は過去 5 年間で年間12%増加しました。
成長の加速: BDXは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: BDXは過去 1 年間で収益成長率がマイナス ( -7.8% ) となったため、 Medical Equipment業界平均 ( 10.4% ) と比較することが困難です。
株主資本利益率
高いROE: BDXの 自己資本利益率 ( 5.6% ) は 低い とみなされます。